A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|180|2|286-290

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.2, 2018-01, pp. : 286-290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Risk and outcome of non‐Hodgkin lymphoma among classical Hodgkin lymphoma survivors

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3385-3392

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two populations of double minute chromosomes harbor distinct amplicons, the MYC locus at 8q24.2 and a 0.43-Mb region at 14q24.1, in the SW613-S human carcinoma cell line

By  

Cytogenetic and Genome Research, Vol. 124, Iss. 1, 2009-04 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

An anergic immune signature in the tumor microenvironment of classical Hodgkin lymphoma is associated with inferior outcome

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 1, 2018-01 ,pp. : 88-97

John Wiley & Sons Inc

Access to resources Recommend Favorite

Yttrium-90 Ibritumomab Tiuxetan-Induced Complete Remission in a Patient with Classical Lymphocyte-Rich Hodgkin’s Lymphoma

By  

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 49-51

Karger

Access to resources Recommend Favorite

Monoclonal antibody therapy for classical Hodgkin lymphoma

By Paszkiewicz-Kozik Ewa   Walewski Jan  

Clinical Investigation, Vol. 3, Iss. 9, 2013-09 ,pp. : 899-910

Future Science

Access to resources Recommend Favorite